| pubmed-article:16469404 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16469404 | lifeskim:mentions | umls-concept:C0687725 | lld:lifeskim |
| pubmed-article:16469404 | lifeskim:mentions | umls-concept:C0003402 | lld:lifeskim |
| pubmed-article:16469404 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:16469404 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:16469404 | lifeskim:mentions | umls-concept:C0001617 | lld:lifeskim |
| pubmed-article:16469404 | lifeskim:mentions | umls-concept:C0205082 | lld:lifeskim |
| pubmed-article:16469404 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:16469404 | pubmed:dateCreated | 2006-3-17 | lld:pubmed |
| pubmed-article:16469404 | pubmed:abstractText | Severe alcoholic hepatitis is associated with high morbidity and short-term mortality. Corticosteroids are the only widely used therapy but established contraindications to treatment or the risk of serious side-effects limit their use. The perceived need for alternative treatments together with the theoretical benefits of anti-oxidant therapy triggered the design of a randomised clinical trial comparing these treatment modalities. | lld:pubmed |
| pubmed-article:16469404 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16469404 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16469404 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16469404 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16469404 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16469404 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16469404 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16469404 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16469404 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16469404 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:16469404 | pubmed:issn | 0168-8278 | lld:pubmed |
| pubmed-article:16469404 | pubmed:author | pubmed-author:PortmannBerna... | lld:pubmed |
| pubmed-article:16469404 | pubmed:author | pubmed-author:DonaldsonNora... | lld:pubmed |
| pubmed-article:16469404 | pubmed:author | pubmed-author:O'GradyJohnJ | lld:pubmed |
| pubmed-article:16469404 | pubmed:author | pubmed-author:PhillipsMarti... | lld:pubmed |
| pubmed-article:16469404 | pubmed:author | pubmed-author:BomfordAdrian... | lld:pubmed |
| pubmed-article:16469404 | pubmed:author | pubmed-author:CurtisHowardH | lld:pubmed |
| pubmed-article:16469404 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16469404 | pubmed:volume | 44 | lld:pubmed |
| pubmed-article:16469404 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16469404 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16469404 | pubmed:pagination | 784-90 | lld:pubmed |
| pubmed-article:16469404 | pubmed:meshHeading | pubmed-meshheading:16469404... | lld:pubmed |
| pubmed-article:16469404 | pubmed:meshHeading | pubmed-meshheading:16469404... | lld:pubmed |
| pubmed-article:16469404 | pubmed:meshHeading | pubmed-meshheading:16469404... | lld:pubmed |
| pubmed-article:16469404 | pubmed:meshHeading | pubmed-meshheading:16469404... | lld:pubmed |
| pubmed-article:16469404 | pubmed:meshHeading | pubmed-meshheading:16469404... | lld:pubmed |
| pubmed-article:16469404 | pubmed:meshHeading | pubmed-meshheading:16469404... | lld:pubmed |
| pubmed-article:16469404 | pubmed:meshHeading | pubmed-meshheading:16469404... | lld:pubmed |
| pubmed-article:16469404 | pubmed:meshHeading | pubmed-meshheading:16469404... | lld:pubmed |
| pubmed-article:16469404 | pubmed:meshHeading | pubmed-meshheading:16469404... | lld:pubmed |
| pubmed-article:16469404 | pubmed:meshHeading | pubmed-meshheading:16469404... | lld:pubmed |
| pubmed-article:16469404 | pubmed:meshHeading | pubmed-meshheading:16469404... | lld:pubmed |
| pubmed-article:16469404 | pubmed:meshHeading | pubmed-meshheading:16469404... | lld:pubmed |
| pubmed-article:16469404 | pubmed:meshHeading | pubmed-meshheading:16469404... | lld:pubmed |
| pubmed-article:16469404 | pubmed:meshHeading | pubmed-meshheading:16469404... | lld:pubmed |
| pubmed-article:16469404 | pubmed:meshHeading | pubmed-meshheading:16469404... | lld:pubmed |
| pubmed-article:16469404 | pubmed:meshHeading | pubmed-meshheading:16469404... | lld:pubmed |
| pubmed-article:16469404 | pubmed:meshHeading | pubmed-meshheading:16469404... | lld:pubmed |
| pubmed-article:16469404 | pubmed:meshHeading | pubmed-meshheading:16469404... | lld:pubmed |
| pubmed-article:16469404 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16469404 | pubmed:articleTitle | Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitis--a randomised clinical trial. | lld:pubmed |
| pubmed-article:16469404 | pubmed:affiliation | Institute of Liver Studies, King's College Hospital, Denmark Hill, London SE5 9RS, UK. | lld:pubmed |
| pubmed-article:16469404 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16469404 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16469404 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16469404 | lld:pubmed |
